Market cap
$126.404 M
$1.18 +6.31%
Close of 7 Aug 2026
Revenue
$33.0M
#2868 by revenue
Earnings
-$44.6M
Loss-making
Shares outstanding
106,861,428
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Commercial Physical & Biological Resarch — ranked by market cap
All 12 →Where these numbers come from
Share counts and financials for Maxcyte are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.